Avenue Therapeutics, Inc. Short Interest Update

ATXI Stock  USD 2.15  0.09  4.37%   
Under 56% of all Avenue Therapeutics' traders are looking to take a long position. The analysis of overall sentiment of trading Avenue Therapeutics stock suggests that some investors are interested at this time. Avenue Therapeutics' investing sentiment shows overall attitude of investors towards Avenue Therapeutics.
  
Avenue Therapeutics, Inc. saw a significant decline in short interest in the month of January. As of January 31st, there was short interest totalling 677,300 shares, a decline of .0 percent from the January 15th total of 1,110,000 shares. Based on an average daily trading volume, of 6,220,000 shares, the days-to-cover

Read at thelincolnianonline.com
news
  

Avenue Therapeutics Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Avenue Therapeutics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Avenue Therapeutics Fundamental Analysis

We analyze Avenue Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Avenue Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Avenue Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Current Valuation

Current Valuation Comparative Analysis

Avenue Therapeutics is currently under evaluation in current valuation category among its peers. Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Avenue Therapeutics Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Avenue Therapeutics stock to make a market-neutral strategy. Peer analysis of Avenue Therapeutics could also be used in its relative valuation, which is a method of valuing Avenue Therapeutics by comparing valuation metrics with similar companies.

Peers

Avenue Therapeutics Related Equities

BDRXBiodexa Pharmaceticals   14.00   
0%
100.0%
QNRXQuoin Pharmaceuticals   1.69   
0%
12.0%
PALIPalisade Bio   1.65   
0%
11.0%
REVBRevelation Biosciences   1.33   
0%
9.0%
HOTHHoth Therapeutics   1.20   
0%
8.0%
NRBONeurobo Pharmaceuticals   0.43   
0%
3.0%
ALLRAllarity Therapeutics   0.90   
6.0%
0%
VRAXVirax Biolabs   4.83   
34.0%
0%
CNSPCns Pharmaceuticals   8.33   
59.0%
0%
WINTWindtree Therapeutics   13.11   
93.0%
0%

Complementary Tools for Avenue Stock analysis

When running Avenue Therapeutics' price analysis, check to measure Avenue Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avenue Therapeutics is operating at the current time. Most of Avenue Therapeutics' value examination focuses on studying past and present price action to predict the probability of Avenue Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avenue Therapeutics' price. Additionally, you may evaluate how the addition of Avenue Therapeutics to your portfolios can decrease your overall portfolio volatility.
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Share Portfolio
Track or share privately all of your investments from the convenience of any device